Rank | Gene Set | Z-score |
---|---|---|
1 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.92243387 |
2 | proteasome assembly (GO:0043248) | 4.52617637 |
3 | valine metabolic process (GO:0006573) | 4.30216756 |
4 | establishment of integrated proviral latency (GO:0075713) | 4.13561742 |
5 | chromatin remodeling at centromere (GO:0031055) | 4.07035544 |
6 | DNA unwinding involved in DNA replication (GO:0006268) | 4.04250020 |
7 | CENP-A containing nucleosome assembly (GO:0034080) | 3.98886907 |
8 | ribosomal small subunit assembly (GO:0000028) | 3.89715770 |
9 | mitotic metaphase plate congression (GO:0007080) | 3.73862972 |
10 | DNA double-strand break processing (GO:0000729) | 3.72629085 |
11 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.72585402 |
12 | glycine metabolic process (GO:0006544) | 3.62789672 |
13 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.62117056 |
14 | IMP biosynthetic process (GO:0006188) | 3.61287500 |
15 | maturation of 5.8S rRNA (GO:0000460) | 3.52330140 |
16 | histone exchange (GO:0043486) | 3.51667332 |
17 | folic acid metabolic process (GO:0046655) | 3.51423850 |
18 | cullin deneddylation (GO:0010388) | 3.51421352 |
19 | rRNA modification (GO:0000154) | 3.51103840 |
20 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.49023412 |
21 | maturation of SSU-rRNA (GO:0030490) | 3.48576774 |
22 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.47149776 |
23 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.45136796 |
24 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.44779890 |
25 | negative regulation of ligase activity (GO:0051352) | 3.44779890 |
26 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.44677950 |
27 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.44677950 |
28 | nuclear pore complex assembly (GO:0051292) | 3.44565890 |
29 | nucleobase biosynthetic process (GO:0046112) | 3.43110168 |
30 | tRNA aminoacylation for protein translation (GO:0006418) | 3.43019548 |
31 | amino acid activation (GO:0043038) | 3.41691468 |
32 | tRNA aminoacylation (GO:0043039) | 3.41691468 |
33 | mitochondrial RNA metabolic process (GO:0000959) | 3.39030251 |
34 | tetrahydrofolate metabolic process (GO:0046653) | 3.37329976 |
35 | one-carbon metabolic process (GO:0006730) | 3.35734521 |
36 | serine family amino acid biosynthetic process (GO:0009070) | 3.34054958 |
37 | protein localization to kinetochore (GO:0034501) | 3.32602801 |
38 | cysteine metabolic process (GO:0006534) | 3.32224908 |
39 | protein deneddylation (GO:0000338) | 3.31968314 |
40 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.30303422 |
41 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.30303422 |
42 | regulation of translational fidelity (GO:0006450) | 3.29851282 |
43 | mitotic nuclear envelope disassembly (GO:0007077) | 3.28686941 |
44 | regulation of mitochondrial translation (GO:0070129) | 3.28562536 |
45 | IMP metabolic process (GO:0046040) | 3.28441721 |
46 | metaphase plate congression (GO:0051310) | 3.27824499 |
47 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.26557433 |
48 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.26557433 |
49 | mitotic sister chromatid segregation (GO:0000070) | 3.26271951 |
50 | nuclear pore organization (GO:0006999) | 3.25618977 |
51 | L-serine metabolic process (GO:0006563) | 3.22983617 |
52 | DNA replication-independent nucleosome organization (GO:0034724) | 3.22357087 |
53 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.22357087 |
54 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.20615832 |
55 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.20231087 |
56 | DNA replication initiation (GO:0006270) | 3.19389465 |
57 | termination of RNA polymerase III transcription (GO:0006386) | 3.17746706 |
58 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.17746706 |
59 | purine nucleobase biosynthetic process (GO:0009113) | 3.17442373 |
60 | peptidyl-histidine modification (GO:0018202) | 3.16544882 |
61 | DNA damage response, detection of DNA damage (GO:0042769) | 3.16472186 |
62 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.13455040 |
63 | non-recombinational repair (GO:0000726) | 3.13455040 |
64 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.13187904 |
65 | serine family amino acid metabolic process (GO:0009069) | 3.10323139 |
66 | spliceosomal snRNP assembly (GO:0000387) | 3.09669353 |
67 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.09030778 |
68 | translational termination (GO:0006415) | 3.08492835 |
69 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.07676732 |
70 | kinetochore organization (GO:0051383) | 3.07598428 |
71 | spindle checkpoint (GO:0031577) | 3.07326295 |
72 | establishment of viral latency (GO:0019043) | 3.06962246 |
73 | rRNA methylation (GO:0031167) | 3.05287350 |
74 | sister chromatid segregation (GO:0000819) | 3.04770417 |
75 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.04013858 |
76 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.04013858 |
77 | regulation of centriole replication (GO:0046599) | 3.03898686 |
78 | ribosome assembly (GO:0042255) | 3.03299107 |
79 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.02802979 |
80 | DNA strand elongation (GO:0022616) | 3.02691491 |
81 | DNA ligation (GO:0006266) | 3.02651562 |
82 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.01337431 |
83 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.01337431 |
84 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.01337431 |
85 | protein K6-linked ubiquitination (GO:0085020) | 3.00964287 |
86 | viral transcription (GO:0019083) | 3.00460636 |
87 | membrane disassembly (GO:0030397) | 2.98978700 |
88 | nuclear envelope disassembly (GO:0051081) | 2.98978700 |
89 | positive regulation of ligase activity (GO:0051351) | 2.98379829 |
90 | mitotic sister chromatid cohesion (GO:0007064) | 2.97859862 |
91 | regulation of DNA endoreduplication (GO:0032875) | 2.97824823 |
92 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.97157266 |
93 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.96894354 |
94 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.96894354 |
95 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.96465352 |
96 | oxaloacetate metabolic process (GO:0006107) | 2.95870497 |
97 | folic acid-containing compound metabolic process (GO:0006760) | 2.95704815 |
98 | mitotic spindle checkpoint (GO:0071174) | 2.95669924 |
99 | dosage compensation (GO:0007549) | 2.95553058 |
100 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.95207733 |
101 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.93583309 |
102 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.93583309 |
103 | translational elongation (GO:0006414) | 2.92586193 |
104 | ribosomal large subunit biogenesis (GO:0042273) | 2.92460216 |
105 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.92379150 |
106 | replication fork processing (GO:0031297) | 2.90716527 |
107 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.89242925 |
108 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.88236930 |
109 | cell cycle G1/S phase transition (GO:0044843) | 2.88236930 |
110 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.87614637 |
111 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.87461533 |
112 | DNA deamination (GO:0045006) | 2.86920808 |
113 | negative regulation of chromosome segregation (GO:0051985) | 2.86699947 |
114 | negative regulation of sister chromatid segregation (GO:0033046) | 2.85981066 |
115 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.85981066 |
116 | negative regulation of RNA splicing (GO:0033119) | 2.85819400 |
117 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.85089725 |
118 | lysine metabolic process (GO:0006553) | 2.83188315 |
119 | lysine catabolic process (GO:0006554) | 2.83188315 |
120 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.83163673 |
121 | regulation of translational termination (GO:0006449) | 2.82072503 |
122 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.75784176 |
123 | UMP biosynthetic process (GO:0006222) | 2.75784176 |
124 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.75784176 |
125 | UMP metabolic process (GO:0046049) | 2.75784176 |
126 | translational initiation (GO:0006413) | 2.75124461 |
127 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.72363240 |
128 | protein localization to chromosome, centromeric region (GO:0071459) | 2.68878316 |
129 | formation of translation preinitiation complex (GO:0001731) | 2.68465383 |
130 | pore complex assembly (GO:0046931) | 2.66419847 |
131 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.64713754 |
132 | translesion synthesis (GO:0019985) | 2.64290126 |
133 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.63663777 |
134 | 2-oxoglutarate metabolic process (GO:0006103) | 2.62858575 |
135 | pseudouridine synthesis (GO:0001522) | 2.62289039 |
136 | negative regulation of mRNA processing (GO:0050686) | 2.62101059 |
137 | nucleoside salvage (GO:0043174) | 2.61987568 |
138 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.61856022 |
139 | ribosome biogenesis (GO:0042254) | 2.59331523 |
140 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.58187004 |
141 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.57748417 |
142 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.55919409 |
143 | DNA duplex unwinding (GO:0032508) | 2.52046314 |
144 | pentose-phosphate shunt (GO:0006098) | 2.51479940 |
145 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.49129913 |
146 | DNA geometric change (GO:0032392) | 2.49117566 |
147 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.48964599 |
148 | DNA replication checkpoint (GO:0000076) | 2.48782692 |
149 | negative regulation of translational initiation (GO:0045947) | 2.48485952 |
150 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.47273159 |
151 | ribosomal small subunit biogenesis (GO:0042274) | 2.46772137 |
152 | response to nitrosative stress (GO:0051409) | 2.43478178 |
153 | rRNA processing (GO:0006364) | 2.41507271 |
154 | glyoxylate metabolic process (GO:0046487) | 2.40080073 |
155 | negative regulation of sterol transport (GO:0032372) | 2.39055599 |
156 | negative regulation of cholesterol transport (GO:0032375) | 2.39055599 |
157 | S-adenosylmethionine metabolic process (GO:0046500) | 2.38679059 |
158 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.38641624 |
159 | pteridine-containing compound metabolic process (GO:0042558) | 2.38588129 |
160 | negative regulation of mRNA metabolic process (GO:1903312) | 2.38424681 |
161 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.38235739 |
162 | isotype switching (GO:0045190) | 2.38235739 |
163 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.38235739 |
164 | protein targeting to ER (GO:0045047) | 2.37251079 |
165 | telomere maintenance via recombination (GO:0000722) | 2.34927216 |
166 | rRNA metabolic process (GO:0016072) | 2.34340856 |
167 | cotranslational protein targeting to membrane (GO:0006613) | 2.33980225 |
168 | NADPH regeneration (GO:0006740) | 2.33902982 |
169 | regulation of gamma-delta T cell activation (GO:0046643) | 2.32065759 |
170 | nuclear envelope organization (GO:0006998) | 2.32009711 |
171 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.31654154 |
172 | T cell apoptotic process (GO:0070231) | 2.31625819 |
173 | erythrocyte maturation (GO:0043249) | 2.30759400 |
174 | tricarboxylic acid metabolic process (GO:0072350) | 2.30594420 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.39826700 |
2 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.87496291 |
3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.73852994 |
4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.16735499 |
5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.84068676 |
6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.72736358 |
7 | MYC_22102868_ChIP-Seq_BL_Human | 2.71266726 |
8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.60852416 |
9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.53346103 |
10 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.51405702 |
11 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.34245647 |
12 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.32899632 |
13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.28311437 |
14 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.23704185 |
15 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.20047795 |
16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.06322759 |
17 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 2.02061688 |
18 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.96728704 |
19 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95722650 |
20 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.95666971 |
21 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.94742044 |
22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.93741593 |
23 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.90328292 |
24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.89320175 |
25 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.88409821 |
26 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.86577090 |
27 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.82182385 |
28 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.80645891 |
29 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.78723173 |
30 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.77787199 |
31 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.77236318 |
32 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.74056437 |
33 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.72426796 |
34 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.71110506 |
35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.70021076 |
36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.68299966 |
37 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.66978235 |
38 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.66858112 |
39 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.66818756 |
40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.64087727 |
41 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.63156350 |
42 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.62964279 |
43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.61569021 |
44 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.61436485 |
45 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.61296125 |
46 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59138388 |
47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.58995548 |
48 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.57679819 |
49 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.57474873 |
50 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.57066182 |
51 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.56275742 |
52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.55452264 |
53 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.51351220 |
54 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.51311621 |
55 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.49618507 |
56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48418536 |
57 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.48414708 |
58 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.47793928 |
59 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.47200335 |
60 | EWS_26573619_Chip-Seq_HEK293_Human | 1.45538676 |
61 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.44825874 |
62 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.43494658 |
63 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43465955 |
64 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.41642141 |
65 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.41466191 |
66 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.41064401 |
67 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.40942464 |
68 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.40295043 |
69 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.39840176 |
70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37155208 |
71 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.30505341 |
72 | MAF_26560356_Chip-Seq_TH1_Human | 1.25665010 |
73 | FUS_26573619_Chip-Seq_HEK293_Human | 1.25361085 |
74 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25278465 |
75 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.24561220 |
76 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.24491709 |
77 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.24221866 |
78 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.23927617 |
79 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22882630 |
80 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.22797968 |
81 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.21289645 |
82 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20616253 |
83 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.20132069 |
84 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19290119 |
85 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18733884 |
86 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.17888007 |
87 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.16247972 |
88 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.15993604 |
89 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.15885795 |
90 | MYB_26560356_Chip-Seq_TH1_Human | 1.15753316 |
91 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.15138048 |
92 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14657241 |
93 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13797113 |
94 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.12912339 |
95 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.12584447 |
96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11369087 |
97 | VDR_22108803_ChIP-Seq_LS180_Human | 1.11237552 |
98 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.10895358 |
99 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.10819469 |
100 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.10320283 |
101 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.09514249 |
102 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.09434678 |
103 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.09422633 |
104 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.09196110 |
105 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.08978061 |
106 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06988119 |
107 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.06170183 |
108 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04996606 |
109 | MYB_26560356_Chip-Seq_TH2_Human | 1.04645384 |
110 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03657275 |
111 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.03227589 |
112 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03170683 |
113 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02274734 |
114 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01552837 |
115 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00745367 |
116 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.00401567 |
117 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.98525288 |
118 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.98484320 |
119 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.98134571 |
120 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.96082393 |
121 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.95472754 |
122 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95219564 |
123 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.93839187 |
124 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.87079785 |
125 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.86714403 |
126 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.85665189 |
127 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.84461198 |
128 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.82685256 |
129 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.82074805 |
130 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.81845200 |
131 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.79281827 |
132 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.79275172 |
133 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.77207057 |
134 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.74004071 |
135 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.72830030 |
136 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.71076352 |
137 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.70427835 |
138 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.69354144 |
139 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.69089763 |
140 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.68171522 |
141 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.68056099 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 3.36431803 |
2 | MP0005360_urolithiasis | 3.23259497 |
3 | MP0002396_abnormal_hematopoietic_system | 2.77628206 |
4 | MP0005365_abnormal_bile_salt | 2.76160996 |
5 | MP0003806_abnormal_nucleotide_metabolis | 2.69792567 |
6 | MP0005085_abnormal_gallbladder_physiolo | 2.68367357 |
7 | MP0003693_abnormal_embryo_hatching | 2.63396556 |
8 | MP0010094_abnormal_chromosome_stability | 2.44896176 |
9 | MP0010352_gastrointestinal_tract_polyps | 2.32246568 |
10 | MP0004957_abnormal_blastocyst_morpholog | 2.26044091 |
11 | MP0000372_irregular_coat_pigmentation | 2.26027401 |
12 | MP0008057_abnormal_DNA_replication | 2.19009252 |
13 | MP0008877_abnormal_DNA_methylation | 2.15313243 |
14 | MP0003718_maternal_effect | 2.10710948 |
15 | MP0003111_abnormal_nucleus_morphology | 2.08522377 |
16 | MP0006054_spinal_hemorrhage | 2.06879602 |
17 | MP0004808_abnormal_hematopoietic_stem | 2.06858055 |
18 | MP0003705_abnormal_hypodermis_morpholog | 2.04874064 |
19 | MP0009697_abnormal_copulation | 2.03996082 |
20 | MP0003077_abnormal_cell_cycle | 1.99806684 |
21 | MP0003656_abnormal_erythrocyte_physiolo | 1.89568651 |
22 | MP0003252_abnormal_bile_duct | 1.89038645 |
23 | MP0009840_abnormal_foam_cell | 1.84279100 |
24 | MP0006035_abnormal_mitochondrial_morpho | 1.83229666 |
25 | MP0005408_hypopigmentation | 1.79697856 |
26 | MP0001545_abnormal_hematopoietic_system | 1.74870812 |
27 | MP0005397_hematopoietic_system_phenotyp | 1.74870812 |
28 | MP0003890_abnormal_embryonic-extraembry | 1.72325860 |
29 | MP0003763_abnormal_thymus_physiology | 1.70060269 |
30 | MP0000685_abnormal_immune_system | 1.68602742 |
31 | MP0010234_abnormal_vibrissa_follicle | 1.65690918 |
32 | MP0003937_abnormal_limbs/digits/tail_de | 1.63948649 |
33 | MP0008875_abnormal_xenobiotic_pharmacok | 1.57856795 |
34 | MP0004147_increased_porphyrin_level | 1.55502549 |
35 | MP0000609_abnormal_liver_physiology | 1.54773343 |
36 | MP0003941_abnormal_skin_development | 1.54418411 |
37 | MP0001529_abnormal_vocalization | 1.52327039 |
38 | MP0008058_abnormal_DNA_repair | 1.50888889 |
39 | MP0000689_abnormal_spleen_morphology | 1.49023552 |
40 | MP0001293_anophthalmia | 1.46303206 |
41 | MP0002398_abnormal_bone_marrow | 1.45666190 |
42 | MP0010307_abnormal_tumor_latency | 1.43794447 |
43 | MP0003300_gastrointestinal_ulcer | 1.40364033 |
44 | MP0002938_white_spotting | 1.40127688 |
45 | MP0002722_abnormal_immune_system | 1.38694845 |
46 | MP0000490_abnormal_crypts_of | 1.38676086 |
47 | MP0002084_abnormal_developmental_patter | 1.38264981 |
48 | MP0010329_abnormal_lipoprotein_level | 1.36844182 |
49 | MP0001188_hyperpigmentation | 1.35419745 |
50 | MP0008789_abnormal_olfactory_epithelium | 1.35041667 |
51 | MP0002102_abnormal_ear_morphology | 1.34900419 |
52 | MP0000358_abnormal_cell_content/ | 1.34767543 |
53 | MP0008007_abnormal_cellular_replicative | 1.33341873 |
54 | MP0003186_abnormal_redox_activity | 1.32264612 |
55 | MP0003136_yellow_coat_color | 1.30758203 |
56 | MP0002160_abnormal_reproductive_system | 1.30568622 |
57 | MP0003221_abnormal_cardiomyocyte_apopto | 1.29315959 |
58 | MP0000703_abnormal_thymus_morphology | 1.29022231 |
59 | MP0002166_altered_tumor_susceptibility | 1.28354861 |
60 | MP0001853_heart_inflammation | 1.27861467 |
61 | MP0009333_abnormal_splenocyte_physiolog | 1.26213110 |
62 | MP0001800_abnormal_humoral_immune | 1.24602507 |
63 | MP0001730_embryonic_growth_arrest | 1.23987520 |
64 | MP0009053_abnormal_anal_canal | 1.23227014 |
65 | MP0002254_reproductive_system_inflammat | 1.22618347 |
66 | MP0000598_abnormal_liver_morphology | 1.22122968 |
67 | MP0000350_abnormal_cell_proliferation | 1.22059832 |
68 | MP0002019_abnormal_tumor_incidence | 1.20865623 |
69 | MP0002085_abnormal_embryonic_tissue | 1.20702488 |
70 | MP0005319_abnormal_enzyme/_coenzyme | 1.17821586 |
71 | MP0005464_abnormal_platelet_physiology | 1.17242781 |
72 | MP0001764_abnormal_homeostasis | 1.16175790 |
73 | MP0006036_abnormal_mitochondrial_physio | 1.15240979 |
74 | MP0002210_abnormal_sex_determination | 1.12145769 |
75 | MP0003191_abnormal_cellular_cholesterol | 1.11610739 |
76 | MP0003303_peritoneal_inflammation | 1.11579747 |
77 | MP0004197_abnormal_fetal_growth/weight/ | 1.11402187 |
78 | MP0005023_abnormal_wound_healing | 1.11043287 |
79 | MP0005083_abnormal_biliary_tract | 1.10476867 |
80 | MP0002086_abnormal_extraembryonic_tissu | 1.09145019 |
81 | MP0010155_abnormal_intestine_physiology | 1.09031703 |
82 | MP0005394_taste/olfaction_phenotype | 1.08981128 |
83 | MP0005499_abnormal_olfactory_system | 1.08981128 |
84 | MP0005076_abnormal_cell_differentiation | 1.08171294 |
85 | MP0004133_heterotaxia | 1.07948377 |
86 | MP0002429_abnormal_blood_cell | 1.07517085 |
87 | MP0001661_extended_life_span | 1.06705564 |
88 | MP0003984_embryonic_growth_retardation | 1.06029884 |
89 | MP0009672_abnormal_birth_weight | 1.05975807 |
90 | MP0002736_abnormal_nociception_after | 1.05785347 |
91 | MP0001929_abnormal_gametogenesis | 1.05384360 |
92 | MP0006072_abnormal_retinal_apoptosis | 1.04278534 |
93 | MP0001666_abnormal_nutrient_absorption | 1.03987836 |
94 | MP0002088_abnormal_embryonic_growth/wei | 1.03165732 |
95 | MP0000647_abnormal_sebaceous_gland | 1.02136786 |
96 | MP0000313_abnormal_cell_death | 1.01616428 |
97 | MP0000716_abnormal_immune_system | 1.01474872 |
98 | MP0003868_abnormal_feces_composition | 1.00719879 |
99 | MP0001915_intracranial_hemorrhage | 1.00689724 |
100 | MP0001697_abnormal_embryo_size | 1.00414032 |
101 | MP0004233_abnormal_muscle_weight | 1.00153031 |
102 | MP0001672_abnormal_embryogenesis/_devel | 1.00077930 |
103 | MP0005380_embryogenesis_phenotype | 1.00077930 |
104 | MP0001984_abnormal_olfaction | 0.99858668 |
105 | MP0002877_abnormal_melanocyte_morpholog | 0.97793073 |
106 | MP0002080_prenatal_lethality | 0.97719008 |
107 | MP0003123_paternal_imprinting | 0.97443915 |
108 | MP0005389_reproductive_system_phenotype | 0.95399124 |
109 | MP0005332_abnormal_amino_acid | 0.94953603 |
110 | MP0001873_stomach_inflammation | 0.94712715 |
111 | MP0002723_abnormal_immune_serum | 0.93717997 |
112 | MP0002452_abnormal_antigen_presenting | 0.93531915 |
113 | MP0010368_abnormal_lymphatic_system | 0.93446784 |
114 | MP0003121_genomic_imprinting | 0.93393479 |
115 | MP0000465_gastrointestinal_hemorrhage | 0.92137015 |
116 | MP0001835_abnormal_antigen_presentation | 0.91856721 |
117 | MP0002233_abnormal_nose_morphology | 0.91552982 |
118 | MP0005387_immune_system_phenotype | 0.91388753 |
119 | MP0001790_abnormal_immune_system | 0.91388753 |
120 | MP0005187_abnormal_penis_morphology | 0.90639589 |
121 | MP0004130_abnormal_muscle_cell | 0.90396729 |
122 | MP0002163_abnormal_gland_morphology | 0.90236070 |
123 | MP0003567_abnormal_fetal_cardiomyocyte | 0.88621317 |
124 | MP0002420_abnormal_adaptive_immunity | 0.88598760 |
125 | MP0000427_abnormal_hair_cycle | 0.88203950 |
126 | MP0008932_abnormal_embryonic_tissue | 0.87338967 |
127 | MP0001145_abnormal_male_reproductive | 0.86781546 |
128 | MP0005075_abnormal_melanosome_morpholog | 0.86472174 |
129 | MP0002111_abnormal_tail_morphology | 0.86313626 |
130 | MP0001819_abnormal_immune_cell | 0.86114546 |
131 | MP0003119_abnormal_digestive_system | 0.85928488 |
132 | MP0002006_tumorigenesis | 0.85140764 |
133 | MP0005671_abnormal_response_to | 0.84951335 |
134 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.84731089 |
135 | MP0002138_abnormal_hepatobiliary_system | 0.84111067 |
136 | MP0003195_calcinosis | 0.84097799 |
137 | MP0000653_abnormal_sex_gland | 0.83368755 |
138 | MP0009278_abnormal_bone_marrow | 0.83226589 |
139 | MP0003755_abnormal_palate_morphology | 0.83115777 |
140 | MP0008469_abnormal_protein_level | 0.82591926 |
141 | MP0003436_decreased_susceptibility_to | 0.81612088 |
142 | MP0004215_abnormal_myocardial_fiber | 0.80626143 |
143 | MP0005220_abnormal_exocrine_pancreas | 0.80538116 |
144 | MP0003786_premature_aging | 0.79782020 |
145 | MP0001919_abnormal_reproductive_system | 0.79780129 |
146 | MP0006292_abnormal_olfactory_placode | 0.79525087 |
147 | MP0000858_altered_metastatic_potential | 0.79056394 |
148 | MP0005666_abnormal_adipose_tissue | 0.78428667 |
149 | MP0002090_abnormal_vision | 0.77842564 |
150 | MP0009703_decreased_birth_body | 0.77492816 |
151 | MP0005379_endocrine/exocrine_gland_phen | 0.76894714 |
152 | MP0008995_early_reproductive_senescence | 0.76381197 |
153 | MP0003943_abnormal_hepatobiliary_system | 0.75688194 |
154 | MP0005084_abnormal_gallbladder_morpholo | 0.75466101 |
155 | MP0001845_abnormal_inflammatory_respons | 0.75186768 |
156 | MP0002118_abnormal_lipid_homeostasis | 0.73587548 |
157 | MP0000015_abnormal_ear_pigmentation | 0.73585331 |
158 | MP0005253_abnormal_eye_physiology | 0.73520848 |
159 | MP0003566_abnormal_cell_adhesion | 0.72757922 |
160 | MP0002697_abnormal_eye_size | 0.72169283 |
161 | MP0002095_abnormal_skin_pigmentation | 0.72048265 |
162 | MP0005171_absent_coat_pigmentation | 0.65994731 |
163 | MP0001727_abnormal_embryo_implantation | 0.65542009 |
164 | MP0001286_abnormal_eye_development | 0.65394726 |
165 | MP0002177_abnormal_outer_ear | 0.63637197 |
166 | MP0008872_abnormal_physiological_respon | 0.62861742 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.84202404 |
2 | Chromsome breakage (HP:0040012) | 3.67007719 |
3 | Hypobetalipoproteinemia (HP:0003563) | 3.64548775 |
4 | Thrombocytosis (HP:0001894) | 3.61273703 |
5 | Entropion (HP:0000621) | 3.29960011 |
6 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.19858762 |
7 | Abnormality of alanine metabolism (HP:0010916) | 3.19858762 |
8 | Hyperalaninemia (HP:0003348) | 3.19858762 |
9 | Deep venous thrombosis (HP:0002625) | 3.15982923 |
10 | Meckel diverticulum (HP:0002245) | 3.11703967 |
11 | Intrahepatic cholestasis (HP:0001406) | 3.03765621 |
12 | Abnormality of the ileum (HP:0001549) | 3.01180175 |
13 | Abnormality of chromosome stability (HP:0003220) | 2.99417693 |
14 | Abnormality of glycolysis (HP:0004366) | 2.97295114 |
15 | Abnormality of the preputium (HP:0100587) | 2.97017141 |
16 | Poikiloderma (HP:0001029) | 2.94765942 |
17 | Increased serum pyruvate (HP:0003542) | 2.94168642 |
18 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.93030095 |
19 | Xanthomatosis (HP:0000991) | 2.92418432 |
20 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.89035539 |
21 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.84141965 |
22 | Acute necrotizing encephalopathy (HP:0006965) | 2.75544300 |
23 | Abnormal lung lobation (HP:0002101) | 2.69441665 |
24 | Acute encephalopathy (HP:0006846) | 2.68226254 |
25 | Hypokinesia (HP:0002375) | 2.66831406 |
26 | Myocardial infarction (HP:0001658) | 2.64215139 |
27 | Abnormality of the labia minora (HP:0012880) | 2.64132690 |
28 | Increased CSF lactate (HP:0002490) | 2.62417184 |
29 | Spastic diplegia (HP:0001264) | 2.56910691 |
30 | Lipid accumulation in hepatocytes (HP:0006561) | 2.55535794 |
31 | Type I transferrin isoform profile (HP:0003642) | 2.52766494 |
32 | Abnormal protein glycosylation (HP:0012346) | 2.52744756 |
33 | Abnormal glycosylation (HP:0012345) | 2.52744756 |
34 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.52744756 |
35 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.52744756 |
36 | Increased serum lactate (HP:0002151) | 2.52262027 |
37 | Acanthocytosis (HP:0001927) | 2.48587440 |
38 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.47314107 |
39 | Abnormal platelet volume (HP:0011876) | 2.46991005 |
40 | Neoplasm of the adrenal gland (HP:0100631) | 2.46681297 |
41 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.45134028 |
42 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.43560969 |
43 | Hypolipoproteinemia (HP:0010981) | 2.43358727 |
44 | Increased mean platelet volume (HP:0011877) | 2.43313653 |
45 | Increased hepatocellular lipid droplets (HP:0006565) | 2.43140550 |
46 | Multiple enchondromatosis (HP:0005701) | 2.42676320 |
47 | Abnormality of the common coagulation pathway (HP:0010990) | 2.39630867 |
48 | Small intestinal stenosis (HP:0012848) | 2.36538818 |
49 | Duodenal stenosis (HP:0100867) | 2.36538818 |
50 | Global brain atrophy (HP:0002283) | 2.36470928 |
51 | Squamous cell carcinoma (HP:0002860) | 2.35946456 |
52 | Ependymoma (HP:0002888) | 2.35872509 |
53 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.34323027 |
54 | Abnormal number of erythroid precursors (HP:0012131) | 2.33432610 |
55 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.32448510 |
56 | Progressive macrocephaly (HP:0004481) | 2.32091507 |
57 | Horseshoe kidney (HP:0000085) | 2.31940788 |
58 | Sloping forehead (HP:0000340) | 2.30332717 |
59 | Hyperlipoproteinemia (HP:0010980) | 2.28015332 |
60 | Hyperammonemia (HP:0001987) | 2.25997222 |
61 | Mitochondrial inheritance (HP:0001427) | 2.21006684 |
62 | Abnormality of the intrinsic pathway (HP:0010989) | 2.20517734 |
63 | Abnormal platelet function (HP:0011869) | 2.20175318 |
64 | Impaired platelet aggregation (HP:0003540) | 2.20175318 |
65 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.19744388 |
66 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.17522635 |
67 | Hepatocellular necrosis (HP:0001404) | 2.15711699 |
68 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.15636223 |
69 | Cerebral edema (HP:0002181) | 2.15039061 |
70 | Reticulocytosis (HP:0001923) | 2.14785733 |
71 | Hyperbilirubinemia (HP:0002904) | 2.14726098 |
72 | Abnormality of reticulocytes (HP:0004312) | 2.14582290 |
73 | Reticulocytopenia (HP:0001896) | 2.14220613 |
74 | Poikilocytosis (HP:0004447) | 2.11693171 |
75 | Hypoglycemic coma (HP:0001325) | 2.11114441 |
76 | Degeneration of anterior horn cells (HP:0002398) | 2.11110795 |
77 | Abnormality of the anterior horn cell (HP:0006802) | 2.11110795 |
78 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.11069773 |
79 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.11069773 |
80 | Hyperacusis (HP:0010780) | 2.09421015 |
81 | Hepatic necrosis (HP:0002605) | 2.05691640 |
82 | Polycythemia (HP:0001901) | 2.05484995 |
83 | Neoplasm of the adrenal cortex (HP:0100641) | 2.03912035 |
84 | Epidermoid cyst (HP:0200040) | 2.03872857 |
85 | Glioma (HP:0009733) | 2.02539682 |
86 | Abnormality of the duodenum (HP:0002246) | 2.02461160 |
87 | Birth length less than 3rd percentile (HP:0003561) | 2.02393867 |
88 | Abnormal cartilage morphology (HP:0002763) | 2.01608309 |
89 | Postnatal microcephaly (HP:0005484) | 2.01231165 |
90 | Abnormal foot bone ossification (HP:0010675) | 2.00749714 |
91 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.99941854 |
92 | Absent radius (HP:0003974) | 1.98441748 |
93 | Hypoplasia of the pons (HP:0012110) | 1.97704661 |
94 | Thoracic kyphosis (HP:0002942) | 1.96748994 |
95 | Lactic acidosis (HP:0003128) | 1.95685544 |
96 | Embryonal renal neoplasm (HP:0011794) | 1.95511995 |
97 | Reduced antithrombin III activity (HP:0001976) | 1.95213464 |
98 | Prolonged bleeding time (HP:0003010) | 1.94271747 |
99 | Testicular atrophy (HP:0000029) | 1.93354198 |
100 | 11 pairs of ribs (HP:0000878) | 1.91852702 |
101 | Abnormality of the thoracic spine (HP:0100711) | 1.90566944 |
102 | Basal cell carcinoma (HP:0002671) | 1.90376517 |
103 | Cerebral hypomyelination (HP:0006808) | 1.90357130 |
104 | Chronic otitis media (HP:0000389) | 1.90181528 |
105 | Microvesicular hepatic steatosis (HP:0001414) | 1.89671465 |
106 | Amaurosis fugax (HP:0100576) | 1.89641346 |
107 | Nausea (HP:0002018) | 1.89564727 |
108 | Neoplasm of the colon (HP:0100273) | 1.88491626 |
109 | Colon cancer (HP:0003003) | 1.88331538 |
110 | Oral leukoplakia (HP:0002745) | 1.88260153 |
111 | Astrocytoma (HP:0009592) | 1.87340232 |
112 | Abnormality of the astrocytes (HP:0100707) | 1.87340232 |
113 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.87217506 |
114 | Deviation of the thumb (HP:0009603) | 1.87209917 |
115 | Cutaneous melanoma (HP:0012056) | 1.87031091 |
116 | Abnormality of the carotid arteries (HP:0005344) | 1.86851798 |
117 | Bifid tongue (HP:0010297) | 1.86847244 |
118 | T lymphocytopenia (HP:0005403) | 1.86800145 |
119 | Hypercholesterolemia (HP:0003124) | 1.86505339 |
120 | Abnormality of serum amino acid levels (HP:0003112) | 1.86473423 |
121 | Absent forearm bone (HP:0003953) | 1.85689063 |
122 | Aplasia involving forearm bones (HP:0009822) | 1.85689063 |
123 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.85651580 |
124 | Epistaxis (HP:0000421) | 1.85027652 |
125 | Areflexia of lower limbs (HP:0002522) | 1.84786772 |
126 | Rhabdomyolysis (HP:0003201) | 1.84496313 |
127 | Mesomelia (HP:0003027) | 1.84003348 |
128 | Abnormality of iron homeostasis (HP:0011031) | 1.83276795 |
129 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.83118015 |
130 | Progressive muscle weakness (HP:0003323) | 1.82959896 |
131 | Proximal placement of thumb (HP:0009623) | 1.82322855 |
132 | Protrusio acetabuli (HP:0003179) | 1.81817989 |
133 | Hepatocellular carcinoma (HP:0001402) | 1.81168616 |
134 | Abnormality of the pons (HP:0007361) | 1.80479345 |
135 | Pallor (HP:0000980) | 1.80450824 |
136 | Hyperglycinemia (HP:0002154) | 1.80198555 |
137 | Progressive inability to walk (HP:0002505) | 1.80149907 |
138 | Methylmalonic acidemia (HP:0002912) | 1.78942036 |
139 | Abnormality of methionine metabolism (HP:0010901) | 1.78790271 |
140 | Prolonged partial thromboplastin time (HP:0003645) | 1.78445720 |
141 | Volvulus (HP:0002580) | 1.77802714 |
142 | Cortical dysplasia (HP:0002539) | 1.77705690 |
143 | Increased nuchal translucency (HP:0010880) | 1.77690417 |
144 | Congenital stationary night blindness (HP:0007642) | 1.77182906 |
145 | Increased serum ferritin (HP:0003281) | 1.77070345 |
146 | Medulloblastoma (HP:0002885) | 1.76981605 |
147 | Pancreatic cysts (HP:0001737) | 1.76771262 |
148 | Hypoplasia of the thymus (HP:0000778) | 1.76340926 |
149 | Increased density of long bones (HP:0006392) | 1.76321344 |
150 | IgM deficiency (HP:0002850) | 1.74945509 |
151 | Pancytopenia (HP:0001876) | 1.74314025 |
152 | Adenoma sebaceum (HP:0009720) | 1.74236303 |
153 | Angiofibromas (HP:0010615) | 1.74236303 |
154 | Abnormality of the fingertips (HP:0001211) | 1.74011886 |
155 | Rhabdomyosarcoma (HP:0002859) | 1.73819324 |
156 | Toxemia of pregnancy (HP:0100603) | 1.72957338 |
157 | Severe short stature (HP:0003510) | 1.72090371 |
158 | Acute myeloid leukemia (HP:0004808) | 1.71189735 |
159 | Ectopic kidney (HP:0000086) | 1.71066987 |
160 | Clubbing of toes (HP:0100760) | 1.70826840 |
161 | Cholelithiasis (HP:0001081) | 1.69683236 |
162 | Selective tooth agenesis (HP:0001592) | 1.69405527 |
163 | Adrenal hypoplasia (HP:0000835) | 1.69348577 |
164 | Urethral obstruction (HP:0000796) | 1.68090145 |
165 | Fat malabsorption (HP:0002630) | 1.68067133 |
166 | Pendular nystagmus (HP:0012043) | 1.67551400 |
167 | Hypoalphalipoproteinemia (HP:0003233) | 1.67338528 |
168 | Lymphoma (HP:0002665) | 1.66338094 |
169 | Renal cortical cysts (HP:0000803) | 1.66280278 |
170 | Molar tooth sign on MRI (HP:0002419) | 1.66249447 |
171 | Abnormality of midbrain morphology (HP:0002418) | 1.66249447 |
172 | Methylmalonic aciduria (HP:0012120) | 1.66230650 |
173 | Rough bone trabeculation (HP:0100670) | 1.66149426 |
174 | Pancreatic fibrosis (HP:0100732) | 1.65359790 |
175 | Abnormality of T cells (HP:0002843) | 1.64743140 |
176 | Abnormal tarsal ossification (HP:0008369) | 1.64567638 |
177 | Abnormality of T cell number (HP:0011839) | 1.63853345 |
178 | Facial cleft (HP:0002006) | 1.63574064 |
179 | Megaloblastic anemia (HP:0001889) | 1.63112260 |
180 | Combined immunodeficiency (HP:0005387) | 1.62859450 |
181 | Myelodysplasia (HP:0002863) | 1.62622603 |
182 | High pitched voice (HP:0001620) | 1.61608858 |
183 | Complement deficiency (HP:0004431) | 1.61326025 |
184 | Microretrognathia (HP:0000308) | 1.61045535 |
185 | Sparse eyelashes (HP:0000653) | 1.60980864 |
186 | 3-Methylglutaconic aciduria (HP:0003535) | 1.60210309 |
187 | Palpitations (HP:0001962) | 1.58227601 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PKN2 | 3.74982663 |
2 | NME2 | 3.33989680 |
3 | MAP4K1 | 2.95421006 |
4 | EEF2K | 2.70830411 |
5 | TRIM28 | 2.66925848 |
6 | CDC7 | 2.66496032 |
7 | EIF2AK1 | 2.43095286 |
8 | PBK | 2.34629846 |
9 | CDK12 | 2.27335955 |
10 | FLT3 | 2.25152065 |
11 | MAP3K10 | 2.20220899 |
12 | PDK2 | 2.14484004 |
13 | PLK3 | 2.13429572 |
14 | TNIK | 2.05499539 |
15 | MST4 | 2.04583320 |
16 | VRK2 | 2.00553120 |
17 | STK10 | 1.95202889 |
18 | TRIB3 | 1.85225564 |
19 | SCYL2 | 1.79183572 |
20 | RPS6KB2 | 1.76690745 |
21 | EIF2AK3 | 1.73439698 |
22 | STK16 | 1.69092176 |
23 | TGFBR1 | 1.64835036 |
24 | MAP2K3 | 1.63630061 |
25 | NUAK1 | 1.62054368 |
26 | ACVR1B | 1.61135216 |
27 | LRRK2 | 1.60242033 |
28 | RPS6KA4 | 1.56951956 |
29 | CDK4 | 1.54899771 |
30 | ZAP70 | 1.50340758 |
31 | WNK3 | 1.47054752 |
32 | BMPR1B | 1.45392234 |
33 | PASK | 1.43730311 |
34 | PTK6 | 1.42008357 |
35 | TTN | 1.38143731 |
36 | WEE1 | 1.37134206 |
37 | ERN1 | 1.36747580 |
38 | BCR | 1.35009419 |
39 | NEK2 | 1.34843805 |
40 | TEC | 1.30016697 |
41 | BTK | 1.28804402 |
42 | TSSK6 | 1.28257171 |
43 | ATR | 1.25682559 |
44 | JAK3 | 1.25637427 |
45 | NME1 | 1.24586927 |
46 | MAP4K2 | 1.22239317 |
47 | TYK2 | 1.20057875 |
48 | TAF1 | 1.19784079 |
49 | MAP3K8 | 1.19644576 |
50 | SRPK1 | 1.19206361 |
51 | WNK4 | 1.17540931 |
52 | BRD4 | 1.14239215 |
53 | GRK6 | 1.10867834 |
54 | MAP3K14 | 1.08933847 |
55 | BCKDK | 1.08590334 |
56 | STK38L | 1.06515838 |
57 | ERBB3 | 1.05358284 |
58 | BRSK1 | 1.04301077 |
59 | EIF2AK2 | 1.01959066 |
60 | CDK6 | 1.01727561 |
61 | STK39 | 0.99487358 |
62 | CHEK2 | 0.99183781 |
63 | PNCK | 0.97794978 |
64 | PIM1 | 0.97639496 |
65 | ALK | 0.97570942 |
66 | AURKB | 0.97453250 |
67 | KDR | 0.97064868 |
68 | NEK1 | 0.94644739 |
69 | LATS1 | 0.93798470 |
70 | CDK7 | 0.91548589 |
71 | CSF1R | 0.91383754 |
72 | FGFR4 | 0.91143834 |
73 | MAP3K12 | 0.89684403 |
74 | CSNK1G1 | 0.89042481 |
75 | PAK2 | 0.88144022 |
76 | TLK1 | 0.86934712 |
77 | MAP3K7 | 0.84726749 |
78 | CSNK1G3 | 0.80294652 |
79 | CASK | 0.77911708 |
80 | BUB1 | 0.77638149 |
81 | TAOK2 | 0.77472057 |
82 | CAMK1D | 0.76624010 |
83 | ERBB4 | 0.75967710 |
84 | MAP2K7 | 0.75218607 |
85 | ITK | 0.75151964 |
86 | CHEK1 | 0.73718306 |
87 | PDK4 | 0.72127354 |
88 | PDK3 | 0.72127354 |
89 | PLK2 | 0.70616912 |
90 | NLK | 0.70523166 |
91 | MAP3K3 | 0.69566627 |
92 | SIK3 | 0.69470291 |
93 | KIT | 0.69087460 |
94 | CSNK1A1L | 0.68587017 |
95 | PAK4 | 0.68533417 |
96 | SIK1 | 0.67211816 |
97 | FGFR1 | 0.66847898 |
98 | PLK1 | 0.66816458 |
99 | TAOK1 | 0.65946263 |
100 | CSNK1G2 | 0.65200856 |
101 | JAK2 | 0.65113040 |
102 | MKNK1 | 0.64247265 |
103 | MTOR | 0.62255555 |
104 | TXK | 0.61814235 |
105 | SYK | 0.60896574 |
106 | ATM | 0.59437780 |
107 | STK4 | 0.58240849 |
108 | STK3 | 0.57244517 |
109 | BRSK2 | 0.56649200 |
110 | TTK | 0.56051555 |
111 | JAK1 | 0.55993438 |
112 | PRKCI | 0.54860673 |
113 | MAP2K6 | 0.54791454 |
114 | MELK | 0.52854256 |
115 | MST1R | 0.52008624 |
116 | TRPM7 | 0.51612044 |
117 | CDK2 | 0.51498741 |
118 | CSNK2A2 | 0.50957033 |
119 | NEK9 | 0.50783871 |
120 | OXSR1 | 0.50435478 |
121 | CCNB1 | 0.49046742 |
122 | PLK4 | 0.48510512 |
123 | CSNK2A1 | 0.48349757 |
124 | CDK8 | 0.48017135 |
125 | VRK1 | 0.47243898 |
126 | CDK3 | 0.46969028 |
127 | AURKA | 0.46943618 |
128 | NTRK3 | 0.46397129 |
129 | CDK1 | 0.45656836 |
130 | CLK1 | 0.45591935 |
131 | MAP3K4 | 0.45480205 |
132 | BLK | 0.45152786 |
133 | ZAK | 0.44568336 |
134 | TBK1 | 0.43384308 |
135 | AKT2 | 0.42382077 |
136 | PIM2 | 0.41926460 |
137 | MKNK2 | 0.41408043 |
138 | RAF1 | 0.40971497 |
139 | CSNK1E | 0.40853007 |
140 | LYN | 0.40218341 |
141 | DYRK3 | 0.39285326 |
142 | TGFBR2 | 0.39030503 |
143 | GRK1 | 0.38053551 |
144 | FRK | 0.37630813 |
145 | LCK | 0.37110517 |
146 | MINK1 | 0.36796492 |
147 | DAPK1 | 0.36092376 |
148 | IRAK3 | 0.33262620 |
149 | BRAF | 0.32797543 |
150 | RPS6KA5 | 0.32152506 |
151 | LIMK1 | 0.31106849 |
152 | PRKDC | 0.28524349 |
153 | EPHA2 | 0.27735323 |
154 | DYRK2 | 0.26290715 |
155 | ADRBK2 | 0.25903875 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 3.00935393 |
2 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.87889373 |
3 | Protein export_Homo sapiens_hsa03060 | 2.68138888 |
4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.50644102 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.27073577 |
6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.27035464 |
7 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.14397170 |
8 | Mismatch repair_Homo sapiens_hsa03430 | 2.11367423 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.11063991 |
10 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.99547239 |
11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.98153871 |
12 | Ribosome_Homo sapiens_hsa03010 | 1.93671384 |
13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.88436699 |
14 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.84273436 |
15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.82456790 |
16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.81897066 |
17 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.80912436 |
18 | RNA transport_Homo sapiens_hsa03013 | 1.80756205 |
19 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.79328178 |
20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.70956512 |
21 | Base excision repair_Homo sapiens_hsa03410 | 1.70830937 |
22 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68720310 |
23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.66831321 |
24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.63223865 |
25 | Spliceosome_Homo sapiens_hsa03040 | 1.63202546 |
26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.56966852 |
27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.53053005 |
28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.52512910 |
29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.50363592 |
30 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.43174430 |
31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.40998326 |
32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.38886359 |
33 | Parkinsons disease_Homo sapiens_hsa05012 | 1.34327842 |
34 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.34081719 |
35 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.33070907 |
36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31133424 |
37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.30347204 |
38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.29225412 |
39 | Cell cycle_Homo sapiens_hsa04110 | 1.25958487 |
40 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.25720052 |
41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22519648 |
42 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.20539233 |
43 | Lysine degradation_Homo sapiens_hsa00310 | 1.17222869 |
44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14265537 |
45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13568374 |
46 | Huntingtons disease_Homo sapiens_hsa05016 | 1.13250711 |
47 | * Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.11448742 |
48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.10265543 |
49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.10224619 |
50 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.07698905 |
51 | RNA polymerase_Homo sapiens_hsa03020 | 1.05337620 |
52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.04198056 |
53 | RNA degradation_Homo sapiens_hsa03018 | 1.04039274 |
54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.02398740 |
55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.97733505 |
56 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.96776965 |
57 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.96742373 |
58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.96557944 |
59 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93535477 |
60 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.90201859 |
61 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.89131003 |
62 | Proteasome_Homo sapiens_hsa03050 | 0.84779747 |
63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82666703 |
64 | Peroxisome_Homo sapiens_hsa04146 | 0.82236006 |
65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.80740679 |
66 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.80624861 |
67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79894598 |
68 | Homologous recombination_Homo sapiens_hsa03440 | 0.79479883 |
69 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.79451836 |
70 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.77331538 |
71 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77304469 |
72 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.77277601 |
73 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.75670055 |
74 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.71228312 |
75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71062407 |
76 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.67853233 |
77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67362830 |
78 | Alzheimers disease_Homo sapiens_hsa05010 | 0.66637555 |
79 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.66438592 |
80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65745931 |
81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.65208315 |
82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.64756504 |
83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.64203452 |
84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63422875 |
85 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61695695 |
86 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.61494021 |
87 | Legionellosis_Homo sapiens_hsa05134 | 0.61345489 |
88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61195127 |
89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60893200 |
90 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60533796 |
91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59668443 |
92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58842040 |
93 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.58046452 |
94 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.56676920 |
95 | Hepatitis B_Homo sapiens_hsa05161 | 0.56065864 |
96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54698050 |
97 | Measles_Homo sapiens_hsa05162 | 0.53579299 |
98 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53578438 |
99 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.53376412 |
100 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.53121189 |
101 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51530003 |
102 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.50436014 |
103 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49810295 |
104 | Basal transcription factors_Homo sapiens_hsa03022 | 0.48755467 |
105 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48021254 |
106 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45945737 |
107 | Phototransduction_Homo sapiens_hsa04744 | 0.45672983 |
108 | Apoptosis_Homo sapiens_hsa04210 | 0.44927137 |
109 | Insulin resistance_Homo sapiens_hsa04931 | 0.42387781 |
110 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.41140534 |
111 | ABC transporters_Homo sapiens_hsa02010 | 0.41132582 |
112 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.40747335 |
113 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.40427764 |
114 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39364698 |
115 | Purine metabolism_Homo sapiens_hsa00230 | 0.38476776 |
116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37777579 |
117 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37268141 |
118 | Viral myocarditis_Homo sapiens_hsa05416 | 0.36500535 |
119 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.35993734 |
120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.34864636 |
121 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.33682071 |
122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32599063 |
123 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31956717 |
124 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.29907577 |
125 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.24382708 |
126 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.23832593 |
127 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.23771669 |
128 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.21988452 |
129 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.20824694 |
130 | Circadian rhythm_Homo sapiens_hsa04710 | 0.13203402 |
131 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.13077427 |
132 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.11655159 |
133 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.09561320 |
134 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.09491560 |
135 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.09358045 |
136 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.08699924 |
137 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.06788806 |